Skip to main content

Table 3 Primary outcome

From: Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trial

LDL-Cholesterol

Intervention group (n = 159)

Control group (n = 157)

Risk difference, % (95% CI)

P

LDL-C < 1.8 mmol/L,* n (%)

44 (37.0)

50 (44.2)

-7.2 (-19.9 to 5.3)

.263

LDL-C (mmol/L), mean (SD)

2.3 (0.7)

2.2 (0.7)

  

eligible participants, n (%)

119 (74.8)

113 (72.0)

  
  1. *Or 50% reduction from pre-treatment value, if this could be identified
  2. LDL-C, low-density lipoprotein cholesterol; n, number; SD, standard deviation
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us